<DOC>
	<DOCNO>NCT00728923</DOCNO>
	<brief_summary>Obsessive-compulsive disorder ( OCD ) common psychiatric illness affect 2-3 % population . People OCD experience anxiety-provoking , intrusive thought , know obsession , feel compel perform repetitive behavior , compulsion . The medication proven effective OCD serotonin reuptake inhibitor ( SRIs ) , even SRI treatment , patient continue experience significant OCD symptom , impaired functioning , diminish quality life . Recent evidence suggest different neurotransmitter , glutamate , may contribute symptom OCD . Medications target glutamate hold promise ameliorate symptom patient continue suffer OCD . In study recruiting patient receive drug NPL-2003 , think modulate neurotransmitter glutamate , add whatever OCD medication take 12-week open label study .</brief_summary>
	<brief_title>Pilot Study Minocycline ( NPL-2003 ) Adults With Obsessive-Compulsive Disorder ( OCD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Primary DSMIV Diagnosis OCD Currently stable adequate dose SRI ( history prior SRI CBT treatment meeting criterion adequate trial ) Patients currently receive SRI CBT include undergone prior SRI CBT trial report interest pursue another DRI CBT trial time . Patients SRIs past must free SRIs least 6 week prior participation YBOCS score great equal 16 Physically health female must use effective contraception Sufficient severity symptom warrant additional augmentation treatment Able provide consent Ongoing treatment antibiotic and/or Accutane . Patients lupus erythematosus Patients plan start CBT study period begin CBT within past 8 week Presence psychotic symptom lifetime history schizophrenia , bipolar disorder psychotic disorder Current major depressive disorder ( patient must free disorder 3 month prior enrollment ) . HAMD must &lt; 18 . Judged clinically risk suicide ( suicidal ideation , severe depression factor Current eat disorder Severe renal insufficiency Documented history hypersensitivity intolerance tetracycline antibiotic Concomitant use anticoagulant drug , antacid , iron , calcium , magnesium , aluminum , zinc sale . Note : Concomitant psychotropic medication antipsychotic benzodiazepine permit long stable least 4 week remain stable course study . Current ETOH/drug abuse dependence disorder dependency past 3 month Female patient either pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>OCD</keyword>
</DOC>